APR-246 is a novel therapeutic molecule and one of the powerful blockers of P53 mutant form and can mediate the P53 refolding and reactivation to induce the apoptosis/cell cycle arrest in tumor cells [26]. This evidence concerns the gene TP53 and neoplasm.